Efficacy and safety of anlotinib combined with immune checkpoint inhibitors and platinum-containing chemotherapy for later-line advanced non-small cell lung cancer: a retrospective three-arm real-world study using propensity-score matching

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Frontiers in Oncology

Topics

Biology

Biochemistry

Medicine

Cancer Oncology

Internal Medicine

Show all topics

DOI

10.3389/fonc.2024.1446950

License

CC-BY